Background

James is a practising respiratory, sleep and general physician currently undertaking a PhD in tuberculosis modelling and epidemiology.

He has experience in public health and tuberculosis control following two years at the Northern Territory Centre for Disease Control as the Tuberculosis Registrar.

Appointments

• Public Health Physician, Burnet Institute, Victoria, Australia

Qualifications

• 2014: FAFPHM, Australasian Faculty of Public Health Medicine
• 2012: FRACP (respiratory, sleep and general medicine), Royal Australasian College of Physicians, Australia
• 2011: MPH, Monash University, Australia
• 2002: MBBS, University of Melbourne, Australia
• 2002: BA, University of Melbourne, Australia

Awards

• 2013: Graham Rouch Award for Best Public Health Medicine Trainee Research in Victoria
• 2013: Best Abstract, Australasian Tuberculosis Conference.

Projects (3)

Past (2)

• 

  Scenario analysis for programmatic tuberculosis control in Western Province, Papua New Guinea

• 

  TB-MAC Multi-modelling Exercise

Publications (26)

2019 (2)

• Profiling Mycobacterium tuberculosis transmission and the resulting disease burden in the five highest tuberculosis burden countries.
  Ragonnet R, Trauer JM, Geard N, Scott N, McBryde ES
  BMC Med. 2019 Nov; 17(1):208
• Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
  Doan TN, Fox GJ, Meehan MT, Scott N, Ragonnet R, Viney K, Trauer JM, McBryde ES
  J Antimicrob Chemother. 2019 Jan; 74(1):218-227

2018 (2)

• Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review.
  Shaweno D, Karmakar M, Alene KA, Ragonnet R, Clements AC, Trauer JM, Denholm JT, McBryde ES
  BMC Med. 2018 Oct; 16(1):193
• Agent-based models of malaria transmission: a systematic review.
  Smith NR, Trauer JM, Gambhir M, Richards JS, Maude RJ, Keith JM, Flegg JA
  Malar J. 2018 Aug; 17(1):299

2017 (3)

• The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains.
  McBryde ES, Meehan MT, Doan TN, Ragonnet R, Marais BJ, Guernier V, Trauer JM
  Int J Infect Dis. 2017 Mar; 56:14-20
• High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
  Ragonnet R, Trauer JM, Denholm JT, Marais BJ, McBryde ES
  BMC Infect Dis. 2017 Jan; 17(1):36
• Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.
  Ragonnet R, Trauer JM, McBryde ES, Houben RM, Denholm JT, Handel A, Sumner T
  Int J Tuberc Lung Dis. 2017 Jan; 21(1):60-66

2016 (4)

• Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.
  Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RM, Kimerling ME, White RG, Vassall A
  Lancet Glob Health. 2016 Nov; 4(11):e816-e826
• Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.
  Houben RM, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG
  Lancet Glob Health. 2016 Nov; 4(11):e806-e815
• Scenario Analysis for Programmatic Tuberculosis Control in Western Province, Papua New Guinea.
  Trauer JM, Denholm JT, Waseem S, Ragonnet R, McBryde ES
  Am J Epidemiol. 2016 May; 183(12):1138-48
• Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%?
  Trauer JM, Moyo N, Tay EL, Dale K, Ragonnet R, McBryde ES, Denholm JT
  Chest. 2016 Feb; 149(2):516-525

2015 (2)

• Vaccination Programs for Endemic Infections: Modelling Real versus Apparent Impacts of Vaccine and Infection Characteristics.
  Ragonnet R, Trauer JM, Denholm JT, Geard NL, Hellard M, McBryde ES
  Sci Rep. 2015 Oct; 5:15468
• Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis.
  Trauer JM, Qian MY, Doyle JS, W Rajaratnam SM, Cunnington D
  Ann Intern Med. 2015 Jun; 163(3):191-204

2014 (1)

• Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-pacific.
  Trauer JM, Denholm JT, McBryde ES
  J Theor Biol. 2014 May; 358:74-84

2013 (4)

• In memoriam: Professor Thomas (Tom) Trauer (1944-2013).
  James Trauer
  Psychooncology. 2013 Oct; 22(10):2159
• Palliative care and hematological malignancies: increased referrals at a comprehensive cancer centre.
  Corbett CL, Johnstone M, Trauer JM, Spruyt O
  J Palliat Med. 2013 May; 16(5):537-541
• Ambulatory oximetry fails to predict survival in chronic obstructive pulmonary disease with mild-to-moderate hypoxaemia.
  Trauer JM, Gielen CA, Aminazad A, Steinfort CL
  Respirology. 2013 Feb; 18(2):377-382
• Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore.
  Trauer JM, Bandaranayake D, Booy R, Chen MI, Cretikos M, Dowse GK, Dwyer DE, Greenberg ME, Huang QS, Khandaker G, Kok J, Laurie KL, Lee VJ, McVernon J, Walter S, Markey PG; Australia, New Zealand and Singapore Pandemic Serosurveillance Study Group.
  Emerg Infect Dis. 2013 Jan; 19(1):92-101

2012 (2)

• Inability of single resting arterial blood gas to predict significant hypoxaemia in chronic obstructive pulmonary disease.
  Trauer JM, Gielen C, Trauer T, Steinfort C
  Intern Med J. 2012 Apr; 42(4):387-394
• Imported malaria in the Northern Territory, Australia--428 consecutive cases.
  Gray TJ, Trauer JM, Fairley M, Krause VL, Markey PG
  Commun Dis Intell Q Rep. 2012 Mar; 36(1):107-113

2011 (5)

• Differential effects of pandemic (H1N1) 2009 on remote and indigenous groups, Northern Territory, Australia, 2009.
  Trauer JM, Laurie KL, McDonnell J, Kelso A, Markey PG
  Emerg Infect Dis. 2011 Sep; 17(9):1615-1623
• Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory.
  Trauer JM, Krause VL
  Med J Aust. 2011 Jun; 194(11):579-582
• Feasibility of latent tuberculosis infection diagnosis by interferon-gamma release assay remote from testing facilities.
  Trauer JM, Hajkowicz KM, Freeman KG, Krause VL
  Commun Dis Intell Q Rep. 2011 Jun; 35(2):168-171
• H1N1 2009 Pandemic Influenza under the microscope
  Markey P, Su J-Y, Wattiaux W, Trauer JM, Krause V
  Micriobiol. 2011 Mar; 32(1):36-38
• The relationship between influenza and invasive pneumococcal disease in the Northern Territory, 2005-2009.
  Edwards LJ, Markey PG, Cook HM, Trauer JM, Krause VL
  Med J Aust. 2011 Feb; 194(4):207

2008 (1)

• The syndrome of inappropriate anti-diuretic hormone secretion concurrent with an acute exacerbation of cystic fibrosis.
  Trauer JM, Wrobel JP, Young AC
  J Cyst Fibros. 2008 Nov; 7(6):573-575

News Articles (1)

2013 (1)

• Burnet launches Campaign to STOP TB